$0.14 3.1%
CDT Stock Price vs. AI Score
Data gathered: September 13

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.


Conduit Pharmaceuticals
Price $0.14
Target Price Sign up
Volume 1,360,000
Market Cap $14M
Year Range $0.12 - $5.19
Dividend Yield 0%
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '24604M3.1M-3.1M-5.4M-3.1M-0.073
Q1 '24536M2.8M-2.8M-3.6M-3M-0.048
Q4 '230810,000-1.1M280,0002.1M-0.015
Q3 '23150,0001.1M-920,0002.6M2M-0.003
Q2 '2318,000380,000-380,000-2.1M-1.7M-0.055

Insider Transactions View All

Tapolczay David filed to sell 200,332 shares at $0.
April 24 '24
Farley Chele Chiavacci filed to buy 203,332 shares at $0.
April 24 '24

What is the Market Cap of Conduit Pharmaceuticals?

The Market Cap of Conduit Pharmaceuticals is $14M.

What is the current stock price of Conduit Pharmaceuticals?

Currently, the price of one share of Conduit Pharmaceuticals stock is $0.14.

How can I analyze the CDT stock price chart for investment decisions?

The CDT stock price chart above provides a comprehensive visual representation of Conduit Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Conduit Pharmaceuticals shares. Our platform offers an up-to-date CDT stock price chart, along with technical data analysis and alternative data insights.

Does CDT offer dividends to its shareholders?

As of our latest update, Conduit Pharmaceuticals (CDT) does not offer dividends to its shareholders. Investors interested in Conduit Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Conduit Pharmaceuticals?

Some of the similar stocks of Conduit Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.